Business Segments · Payments for Restructuring
Prescription Technology Solutions — Payments for Restructuring
Year-over-year, this metric was flat by 0.0%, from $1M to $1M. Over 2 years (FY 2023 to FY 2025), Prescription Technology Solutions — Payments for Restructuring shows a downward trend with a -24.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementSegment
CategoryLiquidity
SignalLower is better
VolatilityVolatile
First reportedQ1 2020
Last reportedQ2 2026Nov 6, 2025
Rolls up toPayments for Restructuring
How to read this metric
High cash payments indicate the active execution phase of restructuring, while lower payments suggest the program is nearing completion.
Detailed definition
Represents the actual cash outflows made to settle liabilities associated with restructuring activities in the Prescript...
Peer comparison
Often found in the 'Cash Flow from Operating Activities' section or segment-level cash flow disclosures of peer companies.
Metric ID:
mck_segment_prescription_technology_solutions_payments_for_restructuringHistorical Data
16 periods
| Q1 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1M | $5M | $2M | $1M | $1M | $3M | $13M | $13M | $2M | $4M | $1M | $1M | $2M | $0 | $0 | $1M |
| QoQ Change | — | +400.0% | -60.0% | -50.0% | +0.0% | +200.0% | +333.3% | +0.0% | -84.6% | +100.0% | -75.0% | +0.0% | +100.0% | -100.0% | — | — |
| YoY Change | — | — | +100.0% | — | — | -40.0% | +550.0% | >999% | +100.0% | +33.3% | -92.3% | -92.3% | +0.0% | -100.0% | -100.0% | +0.0% |
Range$0 – $13M
CAGR+0.0%
Avg YoY Growth+129.9%
Median YoY Growth+0.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's prescription technology solutions — payments for restructuring?
- McKesson (MCK) reported prescription technology solutions — payments for restructuring of $1M in Q3 2025.
- How has McKesson's prescription technology solutions — payments for restructuring changed year-over-year?
- McKesson's prescription technology solutions — payments for restructuring decreased by 0.0% year-over-year, from $1M to $1M.
- What is the long-term trend for McKesson's prescription technology solutions — payments for restructuring?
- Over 2 years (2023 to 2025), McKesson's prescription technology solutions — payments for restructuring has grown at a -24.4% compound annual growth rate (CAGR), from $7M to $4M.
- What does prescription technology solutions — payments for restructuring mean?
- The actual cash spent on executing restructuring plans within the technology solutions segment.